PMDA — authorised 26 March 2019
- Marketing authorisation holder: TEIJIN PHARMA LIMITED
- Status: approved
🇯🇵 Revcovi in Japan
PMDA authorised Revcovi on 26 March 2019
Marketing authorisations
PMDA
- Application: Revcovi
- Local brand name: Revcovi
- Status: approved
Revcovi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Revcovi approved in Japan?
Yes. PMDA authorised it on 26 March 2019; PMDA has authorised it.
Who is the marketing authorisation holder for Revcovi in Japan?
TEIJIN PHARMA LIMITED holds the Japanese marketing authorisation.